Page last updated: 2024-10-29

ifosfamide and Dermatofibrosarcoma

ifosfamide has been researched along with Dermatofibrosarcoma in 1 studies

Dermatofibrosarcoma: A sarcoma of the deep layers of the skin. The tumors are locally aggressive tends to recur but rarely metastatic. It can be classified into variants depending on the cell type tumors are derived from or by its characteristics: Pigmented variant from MELANIN-containing DERMAL DENDRITIC CELLS; Myxoid variant, myxoid STROMAL CELLS; Giant cell variant characterized by GIANT CELLS in the tumors; and Fibrosarcomatous variant chracterized by tumor areas histologically indistinguishable from FIBROSARCOMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miyagawa, T1
Kadono, T1
Kimura, T1
Saigusa, R1
Yoshizaki, A1
Miyagaki, T1
Yamada, D1
Masui, Y1
Fujita, H1
Sato, S1

Other Studies

1 other study available for ifosfamide and Dermatofibrosarcoma

ArticleYear
Pazopanib induced a partial response in a patient with metastatic fibrosarcomatous dermatofibrosarcoma protuberans without genetic translocations resistant to mesna, doxorubicin, ifosfamide and dacarbazine chemotherapy and gemcitabine-docetaxel chemothera
    The Journal of dermatology, 2017, Volume: 44, Issue:3

    Topics: Abdomen; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Deoxy

2017